Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Bonggi Kim
Korea Institute of Drug Safety and Risk Management, Republic of Korea
Poster(s):
(068) Risk of New-onset Type 2 Diabetes Mellitus Associated with 5-Alpha Reductase Inhibitors: A Nationwide Population-Based Study
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
(319) The risk of myocarditis, cardiomyopathy and cutaneous vasculitis associated with quetiapine in patients with schizophrenia and bipolar disorder.
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
